Search results
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
Zacks via Yahoo Finance· 3 hours agoIf Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by...
Legal Implications Following the FDA’s Release of Data on Talc-Containing Cosmetics, Which Confirm...
JD Supra· 8 hours agoIn April, the U.S. Food and Drug Administration (FDA) released the results of its 2023 sampling assignment, testing for asbestos in talc-containing products
FDA must fix “inadequate” inspection and recall policies, report says
Just Food via Yahoo Finance· 23 hours agoSome of those metrics included boosting the FDA's number of inspections, shortening the time it...
FDA and DOJ pledge more cooperation on illegal e-cigarettes ahead of congressional hearing
ABC News· 4 days agoThe Food and Drug Administration said it would launch a new task force on this issue with the...
A guide to safe US sunscreens – and the ingredients to avoid
The Guardian via Yahoo News· 2 days agoWhile all sunscreen provides some amount of UV protection (broad-spectrum products provide the most)...
Male sexual enhancement supplements recalled as unapproved drugs
Consumer Affairs· 1 day agoFDA analysis found these products to be tainted with sildenafil and Tadalafil. Sildenafil/Tadalafil...
FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment
Yahoo Finance· 4 days agoThe FDA's decision does not have to align with the panel's vote. During the panel hearing Monday,...
FDA Issues Warning Letter To Toltrazuril Shop Over Sale Of EPM Medication
Paulick Report· 21 hours ago...the web-based business Toltrazuril Shop, informing the company's management that "introducing or delivering" their toltrazuril products into interstate commerce is prohibited under a portion of the Federal Food, Drug, and Cosmetic ...warning letter is dated May 16 of this year and gives CEO...
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks via Yahoo Finance· 1 day agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 6 hours agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
